Brian Culley is the founder of Lineage Cell Therapeutics. Latest round: IPO. Backed by Roche, Genentech. Based in Carlsbad, California.
Brian Culley is the CEO of Lineage Cell Therapeutics, a publicly traded biotechnology company. He leads development of allogeneic cell therapies for conditions including spinal cord injury, vision loss, hearing loss, diabetes, and cancer. Culley has overseen a corporate partnership with Roche and Genentech valued at up to $670 million for the company's lead vision program.
Full founder directory · Investor directory · Company funding database · Fundraising library